SAN FRANCISCO, March 18, 2013 /PRNewswire/ -- Labrys Biologics Inc., a company focused on treatments for chronic migraine, today announced key executive appointments to lead the development of RN-307, ...

Windows 10/8.1 are good operating systems, but not everyone likes the overall design of the Start Menu. Now, there are several options to change the Start Menu to your liking, but today we’re going to ...

When Helsing raised a $223 million Series B round, the tech world saw it as continued confirmation that defense was unquestionably back on the investing agenda. Further confirmation comes today, in ...

Labrys Biologics Secures $31 Million Series A Financing from Venture Capital Firms; Acquires Phase 2 Ready Antibody for Chronic Migraine from Pfizer SAN FRANCISCO, Jan. 3, 2013 /PRNewswire/ -- Labrys ...